← Leaderboards
Andrea Zawacki Beaton
Cincinnati Childrens Hosp Med Ctr
$4,254,409
Attributed
$8,832,429
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$8,832,429 · 4
By mechanism
R33$3,518,173 · 1
R01$2,430,276 · 1
R61$1,913,148 · 1
D43$970,832 · 1
Top collaborators
- Emmy Okello7 shared
- David A Watkins5 shared
- Nelson K Sewankambo4 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Pirooz Eghtesady$2,834,838
- Emmy Okello$3,039,271
- David A Watkins$1,215,138
- Katherine Ann Scott Auger$1,482,181
- Lilliam Ambroggio$1,335,735
Others in their field
Other Rising Stars on “Low And Middle-Income Countries”
- Steven J. Clipman · Johns Hopkins University$3,453,286
- Saeed Ahmed · Baylor College Of Medicine$3,372,206
- Emmy Okello · Cincinnati Childrens Hosp Med Ctr$3,039,271
- Maria Yazdanbakhsh · Leiden University Medical Center$2,600,040
- Andrea L. Conroy · Indiana University Indianapolis$2,470,944
- Rocio Canals Alvarez · Glaxosmithkline Biologicals$2,427,378
Research focus
Low And Middle-Income CountriesResourcesChildTrainingUgandaGuidelinesRheumatic Heart DiseasePersonsHospitalsInnovationSuccessFundingCountryHeartProgramsCaringAntibiotic ProphylaxisAgedHealth PersonnelEndemic DiseasesCostEnrollmentEchocardiographyAdherence
Grant awards (12)
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)$1,740,115
R33 · FY2025 · HL · contact PI
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)$293,862
R01 · FY2025 · HL · contact PI
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)$276,951
R01 · FY2025 · HL · contact PI
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program$242,643
D43 · FY2025 · TW
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)$1,778,058
R33 · FY2024 · HL · contact PI
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)$573,018
R01 · FY2024 · HL · contact PI
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program$241,595
D43 · FY2024 · TW
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)$1,913,148
R61 · FY2023 · HL · contact PI
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)$606,147
R01 · FY2023 · HL · contact PI
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program$242,449
D43 · FY2023 · TW
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)$680,298
R01 · FY2022 · HL · contact PI
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program$244,145
D43 · FY2022 · TW